OR WAIT null SECS
February 02, 2022
Busy is good for business.
February 01, 2022
Arranta Bio will use Cytiva’s FlexFactory single-use manufacturing platform to produce mRNA vaccines.
Recipharm will build up its biologics service offering with the acquisition of GenIbet.
January 31, 2022
Metagenomi has successfully raised $175 million for use toward its research pipeline.
Both Pfizer and Moderna have started clinical trials for their respective Omicron COVID-19 variant vaccine.
The draft PREVENT Pandemic Act aims to secure supply chains, expand health data collection, and support access to vital medical products
January 28, 2022
IonSense’s DART-MS technology offers rapid drug analysis without the need for sample preparation.
Texcell North America’s new lab facility in Frederick, Md., will expand the CRO’s capabilities in R&D cell culture, viral clearance studies, and viral safety testing.
Refeyn’s SamuxMP enables routine quantification of empty/full AAV capsid ratios, even in smaller labs, to set a new standard in AAV characterization
Samsung Biologics has signed an agreement with Biogen to acquire Biogen’s 50% stake in Samsung Bioepis, a joint venture formed by the two companies, for up to $2.3 billion.
